Literature DB >> 24591316

Limonoids with an oxygen bridge between C(1) and C(29) from the seeds of a Krishna mangrove, Xylocarpus granatum.

Min-Yi Li1, Qiang Xiao, Tirumani Satyanandamurty, Jun Wu.   

Abstract

Ten limonoids, named granatumins L-U (1-10, resp.), were isolated from the seeds of an Indian mangrove, Xylocarpus granatum, collected in the estuary of Krishna, Andhra Pradesh. The structures of these compounds were established on the basis of spectroscopic data. The relative configuration of granatumin L (1) was confirmed by a single-crystal X-ray diffraction analysis. Granatumins L-T (1-9, resp.) belong to the small group of limonoids with an oxygen bridge between C(1) and C(29), while granatumin U (10) is a 28-Me-oxidized mexicanolide. This is the first report of limonoids with an O-bridge between C(1) and C(29) from the Indian X. granatum. The pronounced structural diversity of limonoids from this mangrove might originate from environmental factors.
Copyright © 2014 Verlag Helvetica Chimica Acta AG, Zürich.

Entities:  

Keywords:  Limonoids; Mangroves; X-Ray crystallography; Xylocarpus granatum

Mesh:

Substances:

Year:  2014        PMID: 24591316     DOI: 10.1002/cbdv.201300057

Source DB:  PubMed          Journal:  Chem Biodivers        ISSN: 1612-1872            Impact factor:   2.408


  3 in total

Review 1.  Exploring the Mangrove Fruit: From the Phytochemicals to Functional Food Development and the Current Progress in the Middle East.

Authors:  Fitri Budiyanto; Eman A Alhomaidi; Afrah E Mohammed; Mohamed A Ghandourah; Hajer S Alorfi; Nahed O Bawakid; Wailed M Alarif
Journal:  Mar Drugs       Date:  2022-04-28       Impact factor: 6.085

2.  Limonoids Containing a C₁⁻O⁻C29 Moiety: Isolation, Structural Modification, and Antiviral Activity.

Authors:  Jing-Ling Ren; Xiao-Peng Zou; Wan-Shan Li; Li Shen; Jun Wu
Journal:  Mar Drugs       Date:  2018-11-04       Impact factor: 5.118

3.  TDDFT-ECD and DFT-NMR studies of thaigranatins A-E and granatumin L isolated from Xylocarpus granatum.

Authors:  Attila Mándi; Jun Wu; Tibor Kurtán
Journal:  RSC Adv       Date:  2020-09-01       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.